- Home
- CTNM vs TMQ Comparison
CTNM vs TMQ Comparison
Compare CTNM & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- TMQ
- Stock Information
- Founded
- CTNM 2009
- TMQ 2004
- Country
- CTNM United States
- TMQ Canada
- Employees
- CTNM N/A
- TMQ N/A
- Industry
- CTNM
- TMQ Precious Metals
- Sector
- CTNM
- TMQ Basic Materials
- Exchange
- CTNM Nasdaq
- TMQ Nasdaq
- Market Cap
- CTNM 248.7M
- TMQ 249.6M
- IPO Year
- CTNM 2024
- TMQ N/A
- Fundamental
- Price
- CTNM $12.36
- TMQ $2.11
- Analyst Decision
- CTNM Strong Buy
- TMQ
- Analyst Count
- CTNM 4
- TMQ 0
- Target Price
- CTNM $22.75
- TMQ N/A
- AVG Volume (30 Days)
- CTNM 278.0K
- TMQ 513.9K
- Earning Date
- CTNM 11-05-2025
- TMQ 10-07-2025
- Dividend Yield
- CTNM N/A
- TMQ N/A
- EPS Growth
- CTNM N/A
- TMQ N/A
- EPS
- CTNM N/A
- TMQ N/A
- Revenue
- CTNM N/A
- TMQ N/A
- Revenue This Year
- CTNM N/A
- TMQ N/A
- Revenue Next Year
- CTNM N/A
- TMQ N/A
- P/E Ratio
- CTNM N/A
- TMQ N/A
- Revenue Growth
- CTNM N/A
- TMQ N/A
- 52 Week Low
- CTNM $3.35
- TMQ $0.47
- 52 Week High
- CTNM $20.30
- TMQ $2.16
- Technical
- Relative Strength Index (RSI)
- CTNM 73.06
- TMQ 70.27
- Support Level
- CTNM $10.30
- TMQ $1.78
- Resistance Level
- CTNM $13.26
- TMQ $2.16
- Average True Range (ATR)
- CTNM 1.04
- TMQ 0.13
- MACD
- CTNM 0.03
- TMQ 0.05
- Stochastic Oscillator
- CTNM 77.13
- TMQ 90.83
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.